UnitedHealth Group Inc (UNH) : Rhumbline Advisers scooped up 49,127 additional shares in UnitedHealth Group Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 1,534,849 shares of UnitedHealth Group Inc which is valued at $219,299,225.UnitedHealth Group Inc makes up approximately 0.62% of Rhumbline Advisers’s portfolio.
Other Hedge Funds, Including , Public Sector Pension Investment Board boosted its stake in UNH in the latest quarter, The investment management firm added 26,300 additional shares and now holds a total of 180,169 shares of UnitedHealth Group Inc which is valued at $25,742,547. UnitedHealth Group Inc makes up approx 0.31% of Public Sector Pension Investment Board’s portfolio.Oppenheimer Co Inc boosted its stake in UNH in the latest quarter, The investment management firm added 5,349 additional shares and now holds a total of 64,163 shares of UnitedHealth Group Inc which is valued at $9,151,569. UnitedHealth Group Inc makes up approx 0.26% of Oppenheimer Co Inc’s portfolio.Sterling Investment Management reduced its stake in UNH by selling 421 shares or 3.8% in the most recent quarter. The Hedge Fund company now holds 10,664 shares of UNH which is valued at $1,524,845. UnitedHealth Group Inc makes up approx 2.03% of Sterling Investment Management’s portfolio.Buckingham Asset Management reduced its stake in UNH by selling 272 shares or 2.49% in the most recent quarter. The Hedge Fund company now holds 10,648 shares of UNH which is valued at $1,521,386. UnitedHealth Group Inc makes up approx 0.50% of Buckingham Asset Management’s portfolio.
UnitedHealth Group Inc closed down -0.08 points or -0.06% at $142.01 with 22,95,478 shares getting traded on Tuesday. Post opening the session at $142.73, the shares hit an intraday low of $141.75 and an intraday high of $142.87 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Investors should note that on Aug 3, 2016, UnitedHealth Group Inc announced a cash dividend of $0.6250. The company’s management has announced Sep 7, 2016 as the ex-dividend date and fixed the record date on Sep 9, 2016. The payable date has been fixed on Sep 20, 2016.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.